T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients장기 리툭시맙 치료 환자에서 Sars-Cov2 BNT162b2 Pfizer 백신 3회 투여에 대한 T 세포 반응Article Published on 2022-05-012022-09-12 Journal: European journal of internal medicine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abstract BNT162b2 Pfizer vaccine dose rituximab SARS Cov2 vaccine T-cell Response T-cells T-cells. treated patient [DOI] 10.1016/j.ejim.2022.01.030 PMC 바로가기 [Article Type] Article